Mats Bergman, David Granlund and Niklas Rudholm ()
Additional contact information
Mats Bergman: HUI Research, Postal: SE-10329 Stockholm, Sweden and Södertörn University, SE-14189 Huddinge, Sweden
David Granlund: Umeå University, Postal: SE-90189 Umeå, Sweden
Niklas Rudholm: HUI Research, Postal: SE-10329 Stockholm, Sweden and Dalarna University, SE-79188 Falun, Sweden
Abstract: We study the effect of the degree of exclusivity for the lowest bidder on the average price of generic pharmaceuticals in the short and long terms. Our results indicate that a 1-percentage-point gain in market share of the lowest bidder reduces average costs by 0.3% in the short term and 0.8% in the long term, but also reduces the number of firms by 1%. We find that reducing the number of firms has a strong positive (and hence counteracting) effect on average prices, i.e., a 1% reduction raises prices by approximately 1%.
Keywords: pharmaceutical industry; generic competition; generic drugs; brand-name drugs
38 pages, February 1, 2016
Full text files
BinaryLoader.axd?Own....pdf&Attachment=True
Questions (including download problems) about the papers in this series should be directed to Hans Seerar Westerberg ()
Report other problems with accessing this service to Sune Karlsson ().
RePEc:hhs:huiwps:0116This page generated on 2024-09-13 22:15:10.